Do your part. Volunteer for a COVID-19 clinical trial enrolling now.

Our clinical trial doctors are currently evaluating an investigational vaccine to confirm that it is safe and can effectively protect against COVID-19.

    If you take part in this trial, you may receive:
  • Investigational vaccine or placebo
  • A seasonal influenza vaccine for select patients
  • Reimbursement for reasonable travel expenses if selected to participate
    You may be eligible to participate if you:
  • 18 to 84 years of age
  • At normal or high risk for COVID-19 infection

Trial information

This clinical trial is evaluating an investigational COVID-19 vaccine to make sure it:

1. Works to protect against COVID-19 infection, and

2. Is safe for humans.

What can I expect if I take part?

If you enrol in this trial, you will be assigned to one of two groups:

One group will receive the investigational vaccine, while the other group will receive a placebo injection. A “placebo” injection means that you will receive an injection that looks just like the investigational vaccine, but has no medical benefit.

Some participants will also receive a seasonal flu vaccine, already approved for the general public. This is to make sure that if the investigational vaccine is also approved, these two can be safely and effectively given close to each other—or even at the same time.

Please take the questionnaire to see if this trial may be an option for you.

More About COVID-19

Coronavirus Disease 2019 (COVID-19) results from infection with the virus SARS-CoV-2, which can severely affect the respiratory tract. Common symptoms include coughing, fever, shortness of breath, and sudden loss of taste or smell.

Because of its high rate of transmission, quick onset of severe symptoms, and lack of specific treatment or prevention options, COVID-19 has resulted in a global pandemic with hundreds of thousands of deaths.

Researchers are actively trying to develop ways to prevent the spread of COVID-19. Right now, doctors participating in this clinical trial are testing an investigational (experimental) vaccine to see if it is effective and safe in preventing COVID-19 infection.

Common symptoms:

coughing

fever

shortness of breath

sudden loss of taste or smell

Why should I enrol in clinical research?

If you have ever received a medical treatment or medication, you can thank the volunteers who participated in that specific medication's clinical research for making your healthcare possible.

And during this global pandemic, the role of clinical trial volunteers is more important than ever in making prevention possible.

There are many reasons why people choose to participate in COVID-19 vaccine trials. Some volunteers want early access to possible prevention. Some volunteers want to do their part to get a COVID-19 vaccine ready sooner.

Everyone has had their own experience watching the pandemic unfurl around them, giving everyone a unique reason for joining. As you consider enrolling in an investigational vaccine trial, be sure to carefully consider the pros and cons of joining.

    Pros
  • May receive an investigational vaccine
  • May receive free seasonal flu vaccine
  • Chance to help research that may benefit others
    Cons
  • You may not receive COVID-19 protection
  • You may receive placebo instead of the vaccine
  • Extra time spent on trial tests and visits

Please take the questionnaire to see if this trial may be an option for you.

Frequently asked questions about clinical research

Below we answer some of the most common questions that come up about investigational vaccines and clinical trials.

A clinical trial tests a drug or treatment to see how well it works and how safe it is to use. Clinical trials must be conducted before drugs and treatments can be approved to be used by patients.

This vaccine is being given in a phase III clinical trial, meaning it has already been through two rounds of testing for safety and effectiveness on smaller groups of people. When a vaccine enters phase III, it is being tested on a larger scale as a final step before getting approval to be administered to the general public.

Vaccines are designed to elicit a protective immune response in the individuals that receive the injection. They train the body to first recognize something that causes illness, and then destroy it.

In order to train the body to recognize the target for destruction, a vaccine contains a unique physical aspect of the target. When the vaccine is injected, the body sees it as an invader and uses its systems to destroy it—storing a memory about this substance along the way.

If the body ever encounters this physical aspect again, it will trigger an immune response to destroy whatever is carrying it.

And so, by identifying a distinct physical aspect of COVID-19 and injecting a purified version of it, doctors are hoping to train the body to fight off coronavirus.

Volunteers who participate in vaccine trials help doctors find safe, effective ways to train the body to defend itself against things that can cause disease, such as the coronavirus. Without vaccine trials, there would be no way to confirm that vaccines work and to make sure they don’t produce any unintended consequences.

The data from vaccine research is taken directly to regulatory agencies, who check on whether the vaccines were shown to be safe and effective. If the studies pass, then the vaccine is approved for use by the public.

In the case of COVID-19, developing a vaccine that works would be a powerful next step in preventing further cases—and stopping the pandemic.

No! In this vaccine trial, you will only be receiving a part of the virus. If the vaccine is effective, your body will learn to recognize this part and destroy it—and whatever is carrying it—in the future. If the vaccine is not effective, your body will not mount any response.

In no part of this trial will you be given live COVID-19 as part of the vaccine.

Clinical vaccine trials are regulated by health authorities who set very specific rules and guidelines for them. Any vaccine trial must follow a protocol, which is approved before the trial starts and which contains clear guidelines for how the trial is to be conducted.

Throughout the course of the vaccine trial, your health will be monitored by the trial doctors.

Your privacy will also be protected. The research team cannot share any identifying details about your participation; without your permission, they cannot even share that you are participating in the trial. All the information collected during the trial will be kept confidential, and your name won’t be listed in any reports based on the trial.

Each vaccine trial protocol, or set of instructions for how the trial is to be run, defines when the trial will be over and how many people must enroll in the trial for the results to be applicable to the general public.

Once the vaccine trial is over, the information is collected and analysed to determine the vaccine’s safety, effectiveness, and any side effects.

If a COVID-19 vaccine is approved and widely available in the UK, this study may be stopped early so that volunteers may have access to that vaccine.

Please talk to your doctor or healthcare provider if you have any concerns after the vaccine trial is over.

Yes, you have the right to leave a clinical trial at any time. When you want to leave, tell the trial doctor or research team. It would be helpful if you explain your reasons for leaving, although you don’t have to.